Access Control & AI-Enabled CCTV Systems to streamline Passenger Flow at Railway stations (See 'Corp Brief') IPR - Order passed by Controller of Patents, which lacks independent analysis and is verbatim reproduction of submissions of one party or recommendations of Opposition Board, is procedurally flawed: HC (See 'Legal Desk') Gut Microbiota and Probiotic Science Foundation organises 16th India Probiotic Symposium (See 'Corp Brief') IPR - Overall appearance at first impression is crucial to identify passing off, and meticulous side-by-side dissection is not necessary and trade dress has to be judged as whole: HC (See 'Legal Desk') DPIIT signs MoU with fuel-tech company to support startups (See 'Corp Brief') IBC - Interim arrangement directing parties to maintain status quo, thereby preventing any alteration to nature of principal asset or creation of further third-party interests, should be continued until final disposal by NCLT: SC (See 'Legal Desk') National Council for Cement signs MoU to strengthen skill development (See 'Corp Brief') Misc - Non-public servant can be proceeded against when initial case is registered u/s 13 of PC Act by virtue of Section 107 of IPC: SC (See 'Legal Desk') India preparing for global role in shift towards 'greener' future: MoS (See 'Corp Brief') IBC - Failure to exercise option of higher bid within prescribed timeline results in valid conclusion of auction in favour of highest bidder: NCLAT (See 'Legal Desk') Oriental Insurance crosses Rs 20,000 crore in Gross Premium (See 'Corp Brief') IBC - Non-inclusion of claim in resolution plan results in its extinguishment, and any claim which is not expressly included in resolution plan, and which is not expressly barred as per such plan, cannot be inferred: SC (See 'Legal Desk') 10,000 contributors onboarded on Bhashini Samudaye (See 'Corp Brief') PMLA - Recourse to LOC can be taken by investigating agency in cognizable offences if accused is deliberately evading arrest or not appearing in trial court despite Non-Bailable Warrants: HC (See 'Legal Desk') Supreme Court Clears Path For Single Insolvency Proceedings Against Linked Group Companies (See CORP EINSICHT)

Print

India's First Ferret Research Facility dedicated to Nation

Published: Feb 04, 2025

By TIOLCorplaws News Service

NEW DELHI, FEB 04, 2025: INDIA'S commitment to cutting-edge biomedical research and innovation took a significant leap forward with the dedication of the nation's first Ferret Research Facility, the launch of the GARBH-INi-DRISHTI data repository, and the execution of a key technology transfer agreement. The events, held at the Translational Health Science and Technology Institute (THSTI) in the NCR Biotech Science Cluster, Faridabad, Haryana, were presided over by Dr. Rajesh Gokhale, Director General, Biotechnology Research and Innovation Council and Secretary, Department of Biotechnology on 3rd Feb 2025.

The newly inaugurated THSTI Ferret Research Facility, a state-of-the-art establishment adhering to the highest biosafety and research standards, marks a pivotal moment in India's fight against infectious and non-communicable diseases. This pioneering facility will serve as a crucial resource for vaccine development, therapeutic testing, and research into emerging infectious diseases, significantly bolstering India's pandemic preparedness strategy and positioning the nation at the forefront of global scientific endeavors.

Dr. Gokhale also launched GARBH-INi-DRISHTI, the DBT Data Repository and Information Sharing Hub at THSTI. This groundbreaking platform, developed under the GARBH-INi program, provides access to an unprecedented wealth of clinical data, images, and biospecimens collected from over 12,000 pregnant women, newborns, and postpartum mothers. As one of South Asia's largest maternal and child health databases, GARBH-INi-DRISHTI will empower researchers worldwide to conduct transformative research aimed at improving maternal and neonatal health outcomes. Its foundation lies in collaborative efforts across India's leading research institutions and hospitals, representing a powerful synergy of expertise.

Furthering the drive to translate research into tangible benefits, THSTI executed a Technology Transfer Agreement with M/s Sundyota Numandis Probioceuticals Pvt. Ltd. This agreement facilitates the commercialization of THSTI's innovative, genetically defined synthetic microbial consortium, Lactobacillus crispatus . Isolated from the reproductive tracts of women enrolled in the GARBH-INi cohort, this consortium holds immense promise for nutraceutical applications, promoting overall health and well-being through targeted microbiome-based interventions.

Prof. GanesanKarthikeyan, Executive Director of THSTI, highlighted the institute's strategic role in shaping India's biotech ecosystem, emphasizing its contributions to fostering a robust environment for research and commercialization.

Dr. Gokhale lauded THSTI's commitment to translational research, recognizing the Ferret Facility as a landmark achievement placing India among select nations with such capabilities. He commended the development of GARBH-INi-DRISHTI, emphasizing its potential to empower researchers nationwide in improving birth outcomes. Dr. Gokhale also underscored the importance of technology transfer agreements in driving the biomanufacturing ecosystem and applauded THSTI's efforts in forging industry partnerships for commercialization. These combined initiatives represent a powerful confluence of scientific advancement, data-driven research, and industry collaboration, propelling India towards a healthier and more prosperous future.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.